id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-009417-458rrhcm	Luce, Judith A.	Use of Blood Components in the Intensive Care Unit	2009-05-15		.txt	text/plain	17101	918	43	Benefi ts to the patient with more judicious use of platelet transfusion include decreased donor exposure, which lessens the risk of transfusion-transmitted disease; fewer febrile and allergic reactions that may complicate the hospital course; and the potential delay or prevention of alloimmunization to HLA and platelet antigens. If anti-IgA antibodies are determined to be the cause of this reaction, the patient must receive blood components donated by IgA-defi cient individuals or, if unavailable, specially prepared washed RBCs and platelet concentrates. These patients may have intensive red cell and platelet transfusion requirements and need specialized products such as CMV-negative and irradiated blood components. A blood bank problem uniquely encountered in BMT is the need to switch the patient's ABO group because of an ABO-mismatched transplant, thus necessitating an exchange transfusion of red cells and plasma-containing products (i.e., platelet concentrates) of differing ABO type to avoid hemolysis of donor and recipient cells.	./cache/cord-009417-458rrhcm.txt	./txt/cord-009417-458rrhcm.txt